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A new human coronavirus responsible for severe acute respiratory syndrome (SARS) was identiﬁed in 2003, which raised concern
about coronaviruses as agents of serious infectious disease. Nevertheless, coronaviruses have been known for about 50 years to be
major agents of respiratory, enteric, or systemic infections of domestic and companion animals. Feline and canine coronaviruses
are widespread among dog and cat populations, sometimes leading to the fatal diseases known as feline infectious peritonitis (FIP)
and pantropic canine coronavirus infection in cats and dogs, respectively. In this paper, diﬀerent aspects of the genetics, host cell
tropism, and pathogenesis of the feline and canine coronaviruses (FCoV and CCoV) will be discussed, with a view to illustrating
how study of FCoVs and CCoVs can improve our general understanding of the pathobiology of coronaviruses.
1.Introduction
Coronaviruses are enveloped viruses with a large (27–
32kb) single-stranded, positive-sense RNA [1]. The genome
includes at least 6 open reading frames (ORFs) ﬂanked by
5 and 3 untranslated regions. The viral RNA is packaged
by the nucleocapsid protein (N), which are themselves
enclosed in an envelope containing at least three virally-
encoded membrane proteins: the spike (S) glycoprotein,
transmembrane protein (M), and small membrane protein
(E) [2, 3]. Some coronaviruses have an additional membrane
glycoprotein, hemagglutinin esterase [4].
ThetrimericSproteinformscharacteristicviralpeplom-
ers that are involved in virus attachment to cell receptors
a n di nv i r u s - c e l lf u s i o n[ 5, 6]. The M protein, the most
abundant structural component, is a type III glycoprotein
consisting of a short amino-terminal ectodomain, a triple-
spanning transmembrane domain, and a carboxyl-terminal
inner domain [7]. The E protein has been found to be
important for viral envelope assembly [8].
Coronaviruses infect many animals species, including
cats and dogs. Feline infectious peritonitis (FIP) was ﬁrst
recognized in 1963 at the Angell Memorial Animal Hospital
in Boston by Holzworth [9]. A few years later, Ward discov-
ered that the etiologic agent of this disease was a virus of the
family Coronaviridae, that is, the feline coronavirus (FCoV)
[10]. The ﬁrst observation of canine coronavirus (CCoV)
infection was reported in 1971, when Binn and colleagues
isolated a coronavirus (strain 1-71) from dogs with acute
enteritis in a military canine unit in Germany [11]. Since
these discoveries, much knowledge has been gained as
regarding the molecular biology and pathobiology of these
viruses. This paper describes recent advances in knowledge
of their genetic diversity, the determinants of pathogenesis,
and their ability to cross the species barrier. Diﬀerences and
similarities between these viruses have been highlighted. The
paper focuses on feline and canine coronaviruses of the
Alphacoronavirus genus, and leaves the canine respiratory




2.1. Taxonomy. The family Coronaviridae now comprises
two subfamilies, Coronavirinae and Torovirinae, which dis-
play similarities in morphology, genomic organization, and
gene expression [12, 13]. On the basis of genetic and
serological properties, the Coronavirinae subfamily has been2 Advances in Virology









Figure 1: Genetic relationships between the diﬀerent feline and
canine coronaviruses genotypes (FCoV and CCoV). The feline
sequences are coloured in blue, the canine sequences in orange,
and the porcine sequences in purple. Arrows indicate the putative
sites of recombinations. The genes encoding for the polymerase
polyprotein (pol), the structural spike (S), the envelope (E), the
membrane (M), and the nucleocapsid (N) proteins are indicated.
The genes encoding the accessory proteins are designated by
numerals.
divided into three new genera, Alpha-, Beta-,a n dGamma-
coronavirus (formerly named group 1, 2 and 3, resp.) [14].
Eachgenusissubdividedintodiﬀerentspeciesonthebasisof
sequence identity in the replicase domains of the polyprotein
pp1ab. Representative members of each species are listed
in Table 1. The porcine transmissible gastroenteritis virus
(TGEV), canine coronavirus (CCoV), and feline coronavirus
(FCoV) display greater than 96% sequence identity within
the replicase polyprotein pp1ab, and for this reason have
been grouped in the same species, alphacoronavirus 1,
within the Alphacoronavirus genus [14]( Table 1). Both the
ferret enteric coronavirus (FRECV) and the ferret systemic
coronavirus (FRSCV) also belong to the Alphacoronavirus
genus [15]. Recently, the genome of the mink coronavirus
(MCoV), the etiological agent of catarrhal gastoenteritis
in mink, has been completely sequenced and shows close
genetic relationship with FRECV and FRSCV. The authors
proposed to group the ferret and mink coronaviruses in a
newalphacoronavirus species(alphacoronavirus2)withinthe
Alphacoronavirus genus [16].
2.2. FCoV and CCoV Genotypes. FCoV and CCoV strains
are classiﬁed into 2 main genotypes, which are schematized
in Figure 1, in which their phylogenetic relationships are
highlighted.
Historically, the two FCoV genotypes have been distin-
guished by in vitro virus neutralization assays, using either
type-speciﬁc feline sera or monoclonal antibodies raised
against the S protein [17, 18]. Advances in genetic analyses
have revealed that type II FCoVs originate from a double
recombination between type I FCoV and CCoV, resulting in
a genome principally composed of FCoV sequences but with
the S gene and its adjacent sequences originating from CCoV
[19–22]. FCoV is highly prevalent in catteries, where up to
80% of the animals are seropositive, while in households
10 to 50% of the cats are infected [23]. In the ﬁeld, the




Our knowledge of the molecular biology of CCoV has
accumulated rapidly since the early 2000s. Genetic analysis
of several CCoVs circulating in Italy ﬁrst revealed a new
canine genetic cluster bearing point mutations within the M
genethatincreasedsimilaritytothefelinehomolog[28].The
new genotype was initially designated “FCoV-like CCoVs”.
Further, the S sequence analyse showed that these strains
segregated with FCoV-I (about81% identity) rather than
with the reference CCoVs (about54% identity) [29]. Finally,
on the basis of their geneticrelation to FCoV-I, FCoV-like
CCoVs were designated as CCoV type I and the typical
reference CCoVs have been called CCoV type II [30]. Unlike
FCoVs, the two CCoV genotypes are commonly detected
simultaneously in the same dog, thus allowing genetic
recombination to occur [31, 32]. Recently, an additional
ORF, named ORF3, located between the end of the S gene
and the ORF3a gene, was discovered in CCoV-I strains.
This gene is absent in all other alphacoronaviruses studied
so far (Figure 1). ORF3 encodes a 28kDa N-glycosylated
protein with a cleavable N-terminal signal, the function of
which is unknown [33]. These data provide insight into
the evolutionary history of FCoV and CCoV. It has been
proposed that type I FCoV and CCoV originated from a
common ancestor. CCoV-I may have acquired the ORF3
gene after the divergence of FCoV-I, or, alternatively, FCoV-
I may have lost the ORF3 gene present in their common
ancestor. The acquisition of a new S gene led to the
emergence of CCoV-II, which in turn gave rise to FCoV-II
through recombination with FCoV-I [33].
CCoV and TGEV also appear to be closely linked. TGEV
probably originated from CCoV-II [33, 34]. Subsequent
recombination between these viruses led to the emergence of
a new CCoV-II cluster (formerly named TGEV-like CCoVs),
in which the N-terminus of the spike protein was highly
similar to TGEV whereas the rest of the genome clustered
with reference CCoV-II isolates (Figure 1)[ 35]. Taking into
account this discovery, the CCoV-II genotype has been
subdividedintotwodiﬀerentsubtypes,CCoV-IIaandCCoV-
IIb, comprising reference and TGEV recombinant isolates,
respectively. CCoV-IIb was ﬁrst identiﬁed in Italy and in the
United Kingdom [35, 36] .Ar e c e n ts t u d yw a sc o n d u c t e dt o
establish the prevalence of the various canine genotypes in
Europe. It appeared that CCoV-I accounts for about 20%
of the CCoV infections, and CCoV-II for 44%, with nearlyAdvances in Virology 3
Table 1: Coronavirus genera, species, and representative members.
Genus Species Acronym Host
Alphacoronavirus 1
Transmissible gastroenteritis virus TGEV Pig
Feline enteric coronavirus FECV Feline
Feline infectious peritonitis virus FIPV Feline
Canine coronavirus CCoV Canine
Alphacoronavirus 2a
Ferret enteric coronavirus FRECV Ferret
Ferret systemic coronavirus FRSCV Ferret
Mink coronavirus MCoV Mink
Alphacoronavirus Human coronavirus 229E HCoV-229E Human
Human coronavirus NL63 HCoV-NL63 Human
Porcine epidemic diarrhea virus PEDV Pig
Rhinolophus bat coronavirus HKU2 Rh-BatCoV HKU2 Bat
Scotophilus bat coronavirus 512/05 Sc-BatCoV 512 Bat
Miniopterus bat coronavirus 1 Mi-BatCoV 1 Bat
Miniopterus bat coronavirus HKU8 Mi-BatCoV HKU8 Bat
Betacoronavirus 1
Human coronavirus OC43 HCoV-OC43 Human
Bovine coronavirus BCoV Bovine
Canine respiratory coronavirus CRCoV Canine
Equine coronavirus ECoV Horse
Porcine hemagglutinating encephalomyelitis virus PHEV Pig
Murine coronavirus
Murine hepatitis virus MHV Mouse
Rat sialodacryoadenitis virus SDAV Rat
Betacoronavirus Severe acute respiratory syndrome related coronavirus
Severe acute respiratory syndrome coronavirus SARS-CoV Human
SARS related Rhinolophus bat coronavirus SARSr-Rh-BatCoV Bat
Human coronavirus HKU1 HCoV HKU1 Human
Rousettus bat coronavirus HKU9 Ro-BaCoV HKU9 Bat
Tylonycteris bat coronavirus HKU4 Ty-BatCoV HKU4 Bat
Pipistrellus bat coronavirus HKU5 Pi-BatCoV HKU5 Bat
Avian coronavirus
Infectious bronchitis virus IBV Chicken
Gammacoronavirus Turkey coronavirus TuCoV Turkey
Beluga whale coronavirus SW1 BWCoV SW1 Beluga whale
aProposed as species by Vlasova et al. [16].
36% of infected dogs being coinfected by both genotypes.
Moreover, the CCoV-IIb subtype was detected in 20% of the
CCoV-II infections [37].
2.3. FCoV and CCoV Biotypes. For many years, FCoVs have
been classiﬁed into diﬀerent biotypes on the basis of their
pathobiology.Avirulentstrains,whichusuallyinducemildor
subclinical symptoms, are referred to as feline enteric coro-
navirus (FECV) [38]. Virulent strains cause feline infectious
peritonitis and are called feline infectious peritonitis viruses
(FIPV). Until 2005, CCoVs were considered to be mild
enteropathogens.In2005,avirulentvariantcausingsystemic
disease in pups and mortality was ﬁrst recognized in Italy
[39]. This virulent biotype has been named canine pantropic
coronavirus in reference to its systemic distribution in inter-
nal organs [39, 40]. Interestingly, ferret coronaviruses are
also classiﬁed according to their virulence. The ferret enteric
coronavirus (FRECV), which is widely distributed, causes
an enteric disease called epizootic catarrhal enteritis, whose
overall mortality rate is low [41]. By contrast, the highly
pathogenic ferret systemic coronavirus (FRSCV) induces
FIP-like disease [42, 43].
Bothfelinegenotypesmayberesponsibleformildenteric
orFIPdiseases.FIPremainsarareevent,andonlyaminority4 Advances in Virology
of FCoV-infected cats (up to 10%) develop the illness
[24, 44]. Two forms of FIP are recognized: the wet/eﬀusive
form with accumulation of a characteristic viscous yellow
ﬂuid in body cavities and the dry/noneﬀusive form with
pyogranulomatouslesionsaﬀectingseveralorgans[45].Both
forms are progressive and ultimately fatal [46]. FIP is often
observed in young cats [47, 48]. In ferrets infected with
FRSCV, the gross lesions resemble those described in cats
with the dry form of FIP. Again, histologic lesions are
characterized by severe pyogranulomas commonly observed
in the mesentery and the peritoneal surface [42].
Both canine genotypes have been associated with enteric
CCoV. By contrast, pantropic CCoVs identiﬁed so far all
belong to the CCoV-IIa genetic cluster [49]. Enteric CCoV
infection does not prevent subsequent infection with the
pantropic variant [50]. Dogs seropositive for enteric CCoVs
are still susceptible to pantropic viruses, but the clinical
signs are moderate by comparison with those in seronegative
dogs, probably owing to partial cross-protection induced
by antibodies against enteric CCoV [50]. During infection
with the enteric CCoV, the virus remains restricted to
the gastrointestinal tract. Conversely, the highly virulent
pantropic CCoV is detected at high titres in lungs, spleen,
liver, kidney, and brain [39]. Clinical signs consist of fever,
lethargy, haemorrhagic diarrhoea, severe lymphopenia, and
neurologicalsignsfollowedbydeath[39,49].Theprevalence
of the canine pantropic coronavirus is yet unknown, and
further epidemiological studies are required to determine its
distribution in dog populations. A pantropic strain (CB/05)
has been successfully isolated from the lungs of a dead
pup. CB/05 has subsequently been used to reproduce the
disease experimentally, thereby improving understanding
of this new illness. Infection with the CB/05 strain has
demonstrated that disease outcome depends on the age at
infection. Puppies over 6 months old may recover, whereas
younger puppies (2-3 months) develop the most severe
symptoms [51]. Lymphopenia is one of the main features of
pantropic CCoV infection under natural and experimental
infections. While a transient reduction in T and B cell
populations is observed during the ﬁrst week after infection,
the CD4+ T cell population remains depleted for 30 days
postinfection, which could cause dysfunction of the immune
system and favour opportunistic infections [52].
3. ViralLife Cycle
3.1. Target Cells. The cell tropism of FCoVs and CCoVs
has been studied by experiments conducted in host species.
In the case of FIP, the virus mainly infects cells of the
monocyte/macrophage lineage. Circulating FIPV-infected
monocytes are thought to disseminate the virus to many
organs [45]. Conversely, in asymptomatic cats, FECV is
mainly conﬁned to the intestine and presumed to replicate in
enterocytes. It is believed that the capacity of an FCoV strain
to replicate in monocyte-macrophage cells is correlated with
its virulence [53]. Experiments in which FIPVs and FECVs
were compared for their ability to replicate in isolated
peripheral blood monocytes or in peritoneal macrophages
have corroborated this assumption [53–55]. Monocytes and
macrophages are less likely to support FECV infections.
Furthermore, the viral cycle is less productive than with
FIPV. In comparison, no diﬀerences were noted when the
same experiments were conducted on Crandell feline kidney
(CrFK) cells [55].
The life cycle of canine coronavirus has been essentially
studied in the canine ﬁbrosarcoma cell line (A-72 cells).
Infection led to apoptosis, which may be responsible for
pathology induced by CCoV infection [56, 57]. Like FECV,
enteric CCoV is thought to infect enterocytes, whereas
the cell tropism of pantropic coronavirus remains unclear.
Immunohistochemistry performed on tissues recovered
from infected dogs led to the detection of coronavirus
antigens in macrophages from diﬀerent organs, reminiscent
of FIP infection of cats [40]. Blood monocytes may also
support viral replication, as suggested by the presence of
v i r a lR N Ai nb l o o dl e u c o c y t e s[ 58]. At present, experiments
conducted in isolated blood monocytes or bone marrow-
derived macrophages, such as those described for FIPV,
have not been performed. Such assays may be necessary
in the future to determine the importance of macrophages
in the pathobiology of the pantropic coronavirus. Finally,
the infection of immature lymphocytes cannot be excluded
since high levels of RNA were found in the thymus, possibly
explaining the severe depletion in the CD4+ cell population
[52].
Interestingly, the target cells of ferret coronaviruses are
probably the same as those of FCoVs and CCoVs. Again,
enterocytes are susceptible to the mild FRECV, whereas
macrophages seem to have a pivotal role in the pathobiogen-
esis of the virulent ferret systemic coronavirus [43, 59, 60].
3.2. Attachment and Entry. Like other CoVs, FCoVs and
CCoVs require the viral S protein, a class 1 fusion protein,
for cell entry. Attachment to the cellular receptor is mediated
by the N-terminal domain of the S protein [61], while
fusion of the viral envelope with host cell membranes is
mediated by the C-terminal domain [62]. Like most class
1 fusion proteins, the S protein of CoVs of the beta-a n d
gammacoronavirus genera harbours a cleavage site between
the S1 and S2 domains [63]. Only recently a similar
furin cleavage motif (RRXRR) has been recognized in the
FCoV strains UCD and UCD8 and in the CCoV-I strain
Elmo/02, approximately in the same position as in beta-a n d
gammacoronaviruses [29, 64].
The cellular receptor identiﬁed for the alphacoronavirus
1 species is the aminopeptidase N protein (APN or CD13)
[65]. APN is a 150–160kDa type II glycoprotein and a
metalloprotease. APN is expressed on the cell surface of
epithelial cells of the kidney, intestine, and respiratory tract,
andingranulocytes,monocytes,ﬁbroblasts,endothelialcells,
cerebral pericytes at the blood-brain barrier, and synaptic
membranes in the CNS [66–68]. APN certainly serves as
a receptor for FCoV-II and CCoV-II, but probably not for
FCoV-I and CCoV-I. Using mouse monoclonal antibodies
as blocking agents, Hohdatsu et al. noted diﬀerences in
receptors for type I and II FCoVs and suggested that feline
APN is a receptor only for type II FCoVs [69]. More
recently, Dye et al. produced retroviral pseudotypes thatAdvances in Virology 5
bear the S glycoprotein of type I or type II FCoV and
demonstrated that feline APN is not used by type I FCoV
S glycoprotein for the virus entry [70]. Finally, with chimeric
viruses carrying either a type I or a type II spike, Tekes et
al. conﬁrmed that feline APN is not the functional receptor
of FCoV-I [71]. Considering the strong similarity between
the spikes of CCoV-I and FCoV-I, it is tempting to speculate
that CCoV-I uses the same unknown receptor as FCoV-I.
Certaincoronavirusesalsouseavarietyofcoreceptorsduring
entry, including C-type lectins; indeed L-SIGN facilitates
the infection of both SARS-CoV and HCoV-229E [72, 73].
Regan et al. showed that type-I and -II FCoVs can use DC-
SIGN as a co-receptor for cellular entry [74]. DC-SIGN
is considered to be widely expressed in monocyte-derived
macrophages, which are thought to be the targets of FIPV
infection in vivo [75]. It seems, however, that the FIPV and
FECV biotypes used DC-SIGN in a similar manner, which
suggests that the diﬀerence in cell tropism between these
viruses does not depend on the use of DC-SIGN. The role
of lectins in the entry of CCoVs has not been studied so far.
Coronaviruses enter cells via endocytosis and not via
directfusionoftheviralenvelopewiththeplasmamembrane
[76–78]. It has been shown that HCoV-229E binds human
APN in rafts and enters human ﬁbroblasts through caveolae
[77]. As regarding entry of FCoV-II, studies have been
conducted with the 79-1146 strain, which belongs to the
FIPV biotype. In monocytes, this virus is internalized
throughanovelclathrin-andcaveolae-independentpathway
that depends essentially on dynamin [79]. This is the ﬁrst
report of an internalization pathway with these properties
and further investigation is required to determine whether
use of this pathway is peculiar to the FIPV biotype. At
present, no data have been published concerning the entry
mechanism of CCoVs.
3.3. Replication-Transcription. With most studies focusing
on TGEV or murine hepatitis virus (MHV), gene expression
and replication of FCoV or CCoV have not been speciﬁ-
cally studied as yet. The replicase-transcriptase proteins are
encoded by ORF1a and ORF1b and are initially synthesized
as two large polyproteins, pp1a and pp1ab. These polypro-
teins are processed by two or three viral proteases to generate
16 end products, termed nsp1 to nsp16 [13, 80]. These
cleavageproductsassembleintothereplication-transcription
complex, which promotes genome replication and subge-
nomic mRNA synthesis [81]. The methyltransferase activity
of nsp16 has been extensively studied by using recombinant
FCoV nsp16. Decroly et al. provide experimental evidence
that FCoV nsp16 speciﬁcally binds capped RNAs of 3 to
6 nucleotides in length carrying a methyl group at the N7
position of the guanosine cap, referred as cap-0 structure.
Nsp16 methylates the ribose of the ﬁrst nucleotide of the
RNA and participates in the conversion of viral RNAs from
a cap-0 to a cap-1 structure [82]. This function is probably
common to all coronaviruses.
Like all CoVs, the transcription of FCoVs and CCoVs
is characterized by the production of multiple subgenomic
mRNAs that contain sequences corresponding to both ends
of the genome. The generation of subgenomic mRNAs
involves a process of discontinuous transcription, by mecha-
nisms that have principally been studied in TGEV [83].
4. Role of FCoV andCCoV Proteinsin
Pathogenesis
The molecular determinants that may account for the
dramaticdiﬀerenceinpathogenesisbetweenFECVandFIPV
have been extensively investigated. Today, FIPV is considered
to be a genetic variant of enteric FECV and I shall focus
in this chapter on the mutations probably implicated in
virulence. It is likely, however, that host immunity also plays
a role in the development of FIP. The pantropic CCoV has
been described only recently, and there is little information
about the molecular determinants its increased virulence.
4.1. Role of the Spike Protein. Investigation of recombi-
nant coronaviruses, including MHV, TGEV, and IBV, has
conclusively demonstrated that the spike is an essential
determinant for the pathogenicity of these viruses [84–86].
As regarding FIPV, the spike protein has been identiﬁed as
critical for eﬃcient macrophage infection. A chimeric virus
in which the S protein of FECV strain 79-1683 replaces that
of FIPV 79-1146 poorly infects macrophages, whereas the
high virulent FIPV 79-1146 replicates eﬃciently in this cell
type. Interestingly, the determinant of macrophage tropism
was not localized within the receptor binding domain of
the spike, but rather in the C-terminal domain responsible
for membrane fusion [54]. This study, however, was based
on laboratory strains of FCoV-II, which harbour an S
gene arising from CCoV. More data for FCoV-I strains are
necessary to conﬁrm this hypothesis.
To date, only one pantropic CCoV strain (CB/05) has
been sequenced and compared to avirulent CCoVs. Curi-
ously, the S protein displayed the highest degree of identity
to FCoV-II strain 79-1683. Only residues Pro-73, Asn-125,
and Ala-407 were peculiar to strain CB/05. A substitution at
position 125 (Asp to His instead of to Asn) was also found in
the BGF10 strain, a hypervirulent enteric strain [87].
4.2. Role of the Membrane Protein. Aside from its role in
viral assembly, the coronavirus M protein is believed to
be involved in host interactions. Regarding TGEV, the M
protein has been shown to have interferogenic activity [88].
By comparison of viral sequences from 48 healthy and 8
FIP-infected cats, Brown et al. discovered 5 amino acid
diﬀerences located in the transmembrane domain and in
the cytoplasmic tail of the membrane protein. The authors
suggested that these ﬁndings could be used as diagnostic
markers for FIPV, which would represent a signiﬁcant
advance in management of FIP [89]. This is the ﬁrst study
suggestingarolefortheMproteininFIPVpathogenesis,and
sequences from additional cats with FIP are required to draw
deﬁnitive conclusions.
4.3. Role of the Nucleocapsid Protein. The N protein, which
is necessary for virus assembly, is involved in the formation
of the transcription complex and in pathogenesis, at least6 Advances in Virology
for MHV [90]. The N protein from MHV stimulates the
expression of a gene implicated in the development of
fulminant hepatitis [91, 92]. Two phylogenetic studies have
been conducted on FIPV- and FECV-infected cats. Both
revealed genetic and antigenic variation of N, but without
relation to the FIPV and FECV biotypes [93, 94].
4.4. Role of Accessory Proteins. Coronaviruses encode small
nonstructural proteins of unknown function, which are
speciﬁc to each genus of coronaviruses. The genome of
FCoVs and CCoVs includes two gene clusters encoding
nonstructural proteins: the ORFs 3a, 3b, 3c (located between
the S and E genes) and ORFs 7a, 7b (located downstream of
the N gene). Evidence for their role in the FIPV pathotype
comes from sequence comparisons of FECV and FIPV ﬁeld
strains and from reverse-genetic experiments. Haijema et
al. deleted the gene clusters ORF 3abc or 7ab from the
highly virulent FIPV strain 79-1146 and obtained deletion
mutant viruses that multiplied eﬃciently in cell culture but
that were attenuated in cats [95]. Epidemiological studies
have also corroborated the importance of these genes. FIPV
strains frequently (up to 70% depending on the study) carry
mutations that speciﬁcally inactivate ORF 3c, whilst FECVs
possess a fully functional 3c gene [96–98]. An intact 3c
gene is apparently essential for eﬃcient replication in the
intestinal tract. ORF 3c encodes an accessory triple-spanning
membrane protein, 238 residues in length. Its predicted
topologyissimilartothatoftheMproteinandthe3aprotein
of SARS-CoV, despite their high degree of sequence diversity
[99]. Since some FIPVs appear to have intact 3c genes, it
is likely that alternative mutations can generate the virulent
FIPV biotype.
ORF 7b is speciﬁc to FCoVs, CCoVs, and ferret coro-
naviruses [15, 100]. It encodes a soluble nonstructural
glycoprotein of 24kDa, whose function remains enigmatic
[101]. Like ORF 3c, its expression is not indispensable for
in vitro replication. Conversely, in almost all natural FECV
infections, ORF 7b is maintained and the appearance of
an FIPV biotype often correlates with the loss of ORF
7b expression [89, 98]. Nevertheless, another study has
suggested that 7b deletion occurs in both FIPV and FECV
infections [102]. Altogether, the switch from FECV to FIPV
could be a multistep process, involving mutations in at least
the S and accessory genes. Complete sequences of FECV
and FIPV ﬁeld strains will be necessary to validate this
assumption.
Regarding the pantropic CCoV, the most striking genetic
marker identiﬁed in the unique pantropic CCoV genome
sequenced (strain CB/05) consisted of a 38-nt deletion
in ORF3b, which is predicted to give rise to a truncated
nonstructural protein 3b [39, 49]. This observation needs to
be conﬁrmed by analysis of additional pantropic sequences.
5. InterspeciesTransmission
Coronaviruses are characterized by a signiﬁcant capacity for
genetic change that enables them to adapt to new hosts
andecologicalniches,sometimescausingzoonoticoutbreaks
with disastrous consequences like the SARS epidemic in
2003 [103]. In this chapter, I shall discuss the possibility of
heterospeciﬁc coronavirus infections in cats or dogs.
5.1. The Speciﬁc Properties of Feline APN. In general, the
APN receptor is used by alphacoronaviruses in a species-
speciﬁc manner, that is, human APN is the cellular receptor
for HCoV-229E, but not for the porcine coronaviruses, and
conversely, porcine APN serves as a receptor for the porcine
coronaviruses, but not for HCoV-229, FCoV, or CCoV
[104, 105]. However, feline APN is a functional receptor
for many alphacoronaviruses, including feline (FECV and
FIPV), human (HCoV-229E), porcine (TGEV), and canine
coronaviruses [106]. Human, feline, and porcine APN show
strong amino acid conservation and display about 78%
identity. Yet, species-speciﬁc tropism is inﬂuenced by minor
diﬀerences in certain regions of APN [107]. Chimeras of
mouse-feline APN were used by Tusell et al. to identify the
threesmall,discontinuousregionsinfelineAPNthatarecrit-
ical determinants for the host range of these coronaviruses.
Amino acids (aa) 288 to 290 are essential for the entry of
HCoV-229E, particularly the presence of an N-glycosylation
sequon prevents virus infection. TGEV requires the region
corresponding to aa 732 to 746 of feline APN, while FCoV
and CCoV necessitate both aa 732 to 746 and aa 764 to 788
for entry [108]. The entry of all of these viruses is blocked by
the same monoclonal antibody directed against feline APN,
suggesting that these three regions are closely link together
in the three dimensional structure of feline APN. HCoV-
229E, FCoV, TGEV, and CCoV probably evolved from the
same ancestral alphacoronavirus, which may have infected
cats using feline APN. The selection of mutations in the S
protein may then have led to the appearance of viruses able
to infect other host species by means of their cognate APN
proteins, although all of them retained their capacity to use
feline APN as a receptor in vitro.
5.2. Cross-Species Jump between Cats and Dogs? Considering
the exceptional properties of feline APN, cats could be
infected by HCoV-229E, TGEV, or CCoV. In vivo, under
experimental conditions, cats can be infected with CCoV
and with human HCoV-229E without developing symptoms
[109–111]. However, nonfeline coronaviruses have never
been formally reported in naturally infected cats. Consider-
ing the close genetic relationship between feline and canine
coronaviruses, interspeciﬁc circulation of either CCoV in
cats or FCoV in dogs is plausible. The genomic organisation
of FCoV-II strongly suggests that coinfection with FCoV-I
and CCoV-II occurred in one of these species, which led,
after a double recombination event, to the emergence of
FCoV-II. Moreover, FCoV-I/CCoV-I and FCoV-II/CCoV-II
have a highly similar spike, which is a crucial determinant of
the host species. In 2006, a study performed in an Austrian
shelter and based on phylogenetic analysis of a fragment of
the M gene did indeed suggest that some cats were infected
with CCoV-I [112]. However, since the ORF3 gene had not
been described at this time, it was impossible to conﬁrm that
these atypical strains belonged to the CCoV-I genotype.Advances in Virology 7
Beyond the alphacoronaviruses, cats are also susceptible
to SARS-CoV replication. After intratracheal inoculation,
infected animals shed the virus from the pharynx from 2 to
10 days postinfection and transmitted the virus to animals
with which they were in close contact [113]. Although
none of the infected cats developed any symptoms, mild
pulmonaryhistologiclesionswereobservedintheseanimals.
Experiments in which coronaviruses other than CCoVs
have been administered to dogs have never been performed,
and in the ﬁeld only CCoVs sequences have been recovered
from infected animals. However, sequence comparisons
suggest that TGEV resulted from a cross-species jump of
CCoV-II from dogs to pigs [34]. Furthermore, CCoV-IIb,
only recently described, results from a double recombination
between CCoV-II and TGEV, suggesting that coinfection has
occurred in at least one host species [18].
6. Conclusion
Coronaviruses display unique molecular mechanisms of
transcriptionandrecombination.Oneofthemostimportant
insights gained over the past several years is that coron-
aviruses have crossed and in all likelihood will continue
to cross between species, thus causing emerging disease in
new host species, as was the case with the SARS epidemic
in 2003. Coronaviruses of companion animal species were
described long before the emergence of SARS-CoV. They
exemplify the distinctive features of coronaviruses; that is,
the presence of diﬀerent biotypes and genotypes within each
species, the critical role of accessory proteins in virulence
and the possibility of interspecies transmission. FCoVs and
CCoVs are common pathogens and readily evolve. It is
necessary to pursue epidemiological surveillance of these
viruses, so as to detect the emergence of new variants,
which may have increased pathogenicity and/or a new host
range,asearlyaspossible.Theknowledgeaccumulatedabout
FCoVs and CCoVs, summarized in this paper, has made a
substantial contribution to the understanding of the genetic
evolution and pathobiology of coronaviruses. Observations
that the spike protein and the accessory proteins contribute
to pathogenesis and to host range have greatly beneﬁted
molecular investigation of the SARS-CoV. The next major
goalwillbetodeﬁnethemoleculardeterminantsofvirulence
and tropism. Progress in these ﬁelds will require a better
comprehension of the interactions between viral and host
proteins and to what extent they are coronavirus- and organ-
speciﬁc. In this context, study of FCoVs and CCoVs, as
representative members of the Coronaviridae family, will
again be helpful.
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